| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 218 | 2022 |
| Redefining fatty liver disease: an international patient perspective G Shiha, M Korenjak, W Eskridge, T Casanovas, P Velez-Moller, ... The lancet Gastroenterology & hepatology 6 (1), 73-79, 2021 | 200 | 2021 |
| Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4 W Doss, G Shiha, M Hassany, R Soliman, R Fouad, M Khairy, W Samir, ... Journal of hepatology 63 (3), 581-585, 2015 | 186 | 2015 |
| Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa G Shiha, K Alswat, M Al Khatry, AI Sharara, N Örmeci, I Waked, ... The lancet Gastroenterology & hepatology 6 (1), 57-64, 2021 | 153 | 2021 |
| Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II … I Waked, G Shiha, RB Qaqish, G Esmat, A Yosry, M Hassany, R Soliman, ... The Lancet Gastroenterology & Hepatology 1 (1), 36-44, 2016 | 106 | 2016 |
| Factors associated with delayed cancer diagnosis in Egyptian children ER Abdelkhalek, LM Sherief, NM Kamal, RM Soliman Clinical Medicine Insights: Pediatrics 8, CMPed. S16413, 2014 | 74 | 2014 |
| An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project G Shiha, AM Metwally, R Soliman, M Elbasiony, NNH Mikhail, ... The Lancet Gastroenterology & Hepatology 3 (11), 778-789, 2018 | 66 | 2018 |
| Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt G Shiha, G Esmat, M Hassany, R Soliman, M Elbasiony, R Fouad, ... Gut 68 (4), 721-728, 2019 | 64 | 2019 |
| Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective study G Shiha, N Mousa, R Soliman, N NNH Mikhail, M Adel Elbasiony, ... Journal of viral hepatitis 27 (7), 671-679, 2020 | 62 | 2020 |
| Batch bioethanol production via the biological and chemical saccharification of some Egyptian marine macroalgae RM Soliman, SA Younis, NS El‐Gendy, SSM Mostafa, SA El‐Temtamy, ... Journal of Applied Microbiology 125 (2), 422-440, 2018 | 59 | 2018 |
| GES: a validated simple score to predict the risk of HCC in patients with HCV‐GT4‐associated advanced liver fibrosis after oral antivirals G Shiha, I Waked, R Soliman, M Elbasiony, A Gomaa, NNH Mikhail, ... Liver International 40 (11), 2828-2833, 2020 | 51 | 2020 |
| Characteristics of systemic lupus erythematosus in a sample of the Egyptian population: a retrospective cohort of 1109 patients from a single center KT El Hadidi, BM Medhat, NM Abdel Baki, H Abdel Kafy, ... Lupus 27 (6), 1030-1038, 2018 | 49 | 2018 |
| An educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages G Shiha, R Soliman, NNH Mikhail, P Easterbrook Journal of Hepatology 72 (4), 658-669, 2020 | 45 | 2020 |
| Sofosbuvir plus Daclatasvir with or without ribavirin for treatment of chronic HCV genotype 4 patients: real-life experience MN Shiha Gamal, Soliman Reham, ElBasiony Mohamed, Hassan Ayman Hepatology International, 2018 | 42 | 2018 |
| A same day ‘test and treat’model for chronic HCV and HBV infection: results from two community‐based pilot studies in Egypt G Shiha, R Soliman, A Serwah, NNH Mikhail, T Asselah, P Easterbrook Journal of viral hepatitis 27 (6), 593-601, 2020 | 38 | 2020 |
| Current coronavirus (SARS-CoV-2) epidemiological, diagnostic and therapeutic approaches: An updated review until June 2020 A Nabil, K Uto, MM Elshemy, R Soliman, AA Hassan, M Ebara, G Shiha EXCLI journal 19, 992, 2020 | 38 | 2020 |
| Usability and acceptability of self-testing for hepatitis C virus infection among the general population in the Nile Delta region of Egypt EI Reipold, A Farahat, A Elbeeh, R Soliman, EB Aza, MS Jamil, ... BMC Public Health 21, 1-11, 2021 | 30 | 2021 |
| Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: analysis of a global dataset JM Freiman, J Wang, PJ Easterbrook, CR Horsburgh, F Marinucci, ... Journal of hepatology 71 (1), 62-70, 2019 | 26 | 2019 |
| Sofosbuvir plus ribavirin in the treatment of Egyptian patients with chronic genotype 4 HCV infection GE Esmat, G Shiha, RF Omar, M Hassany, R Hammad, M Khairy, W Samir, ... Hepatology 60, 662A-663A, 2014 | 25 | 2014 |
| Sensitivity and specificity of microRNA-204, CA125, and CA19. 9 as biomarkers for diagnosis of ovarian cancer FT Ali, RM Soliman, NS Hassan, AM Ibrahim, MM El-Gizawy, ... PLoS One 17 (8), e0272308, 2022 | 22 | 2022 |
Gamal E. ShihaProfessor of Internal Medicine, Mansoura University確認したメール アドレス: mans.edu.eg